Predicting CAR-T outcomes in R/R DLBCL: a multicenter real-world study of a 5-index model

IntroductionThe clinical management of relapsed or refractory diffuse large B‑cell lymphoma (R/R DLBCL) has been transformed by chimeric antigen receptor T‑cell therapy (CAR‑T), yet a significant challenge remains in predicting which patients will derive long‑term benefit.MethodsThis multicenter ret...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Bin Xue, Huina Lu, Yifan Liu, Ying Lu, Wenjun Zhang, Bing Xiu, Xiu Luo, Li Wang, Wenbin Qian, Aibin Liang, Ping Li
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2026-06-01
Serie:	Frontiers in Immunology
Soggetti:	CAR-T DLBCL multicenter prediction model real-world
Accesso online:	https://www.frontiersin.org/articles/10.3389/fimmu.2026.1863194/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!